Phoenix News Desk

Cryptococcal Meningitis Market is Expected to Expand at a Healthy Growth Rate by 2030 | Key Companies – Gilead Sciences, TTY Biopharm, Matinas BioPharma, and Others

 Breaking News
  • No posts were found

Cryptococcal Meningitis Market is Expected to Expand at a Healthy Growth Rate by 2030 | Key Companies – Gilead Sciences, TTY Biopharm, Matinas BioPharma, and Others

October 20
03:53 2021
Cryptococcal Meningitis Market is Expected to Expand at a Healthy Growth Rate by 2030 | Key Companies - Gilead Sciences, TTY Biopharm, Matinas BioPharma, and Others
Delveinsight Business Research LLP
DelveInsight’s “Cryptococcal Meningitis Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Cryptococcal Meningitis Market Size and Share in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Cryptococcal Meningitis market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2017 to 2030. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Cryptococcal Meningitis: An Overview

Cryptococcal Meningitis (CM) is a severe infection of the brain and spinal column that can occur in people living with HIV. CM is caused by a fungus called Cryptococcus neoformans, and results in inflammation and swelling of the brain; it can be extremely debilitating and/or painful, which can damage the brain. Also, the fungus can cause disease in the lungs, and less commonly, in the kidneys, skin, urinary tract, and lymph node.

According to the “Centers for Disease Control and Prevention (CDC),” Cryptococcus neoformans is a fungus that is present in the environment throughout the world. Most people get exposed to the microscopic fungus as a child, but they never get sick from it. Still, in people with weakened immune systems such as those living with HIV/AIDS, Cryptococcus can stay hidden in the body and later become a serious (but not contagious) brain infection called Cryptococcal Meningitis.

Cryptococcal Meningitis Market Key Facts

  • As per the study conducted by J. Eric Piña-Garza MD et al. (2019), Cryptococcal meningitis is uncommon before age 10, and perhaps only 10% of cases occur before age 20.

  • As per the Delveinsight, Cryptococcal Meningitis occurs more frequently in males than in Females

Get FREE sample copy at: Cryptococcal Meningitis Therapeutics Market

Key Benefits of Cryptococcal Meningitis Market Report

  • The report provides an in-depth analysis of Cryptococcal Meningitis Market Size and Share till 2030 in the seven major markets.

  • The report will help in developing business strategies by understanding the Cryptococcal Meningitis Market Trends, key players, and ongoing developments that shape and drive the market growth in the upcoming years.

  • It covers Cryptococcal Meningitis current treatment practices, emerging drugs, market share of the individual therapies in the 7MM.

  • The report provides a detailed assessment of the Cryptococcal Meningitis market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Cryptococcal Meningitis Market 

The Cryptococcal Meningitis market size is anticipated to increase for the study period owing to the rise in the number of incident cases of Cryptococcal Meningitis patients in the 7MM. Extensive research and development activities of pharmaceutical companies for developing the drugs that are under clinical trial for therapies targeting Cryptococcal Meningitis will also impact the market significantly.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Cryptococcal Meningitis market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Cryptococcal Meningitis market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Cryptococcal Meningitis Epidemiology

The epidemiology section covers insights about the historical and current Cryptococcal Meningitis patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Cryptococcal Meningitis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cryptococcal Meningitis market or expected to get launched in the market during the study period. The analysis covers Cryptococcal Meningitis market uptake by drugs; patient uptake by therapies; and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Cryptococcal Meningitis Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

The dynamics of Cryptococcal Meningitis market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the diseases, incremental healthcare spending across the world, and the expected the launch of emerging therapies.

Cryptococcal Meningitis Companies:

  • Gilead Sciences

  • TTY Biopharm Company Limited

  • Matinas BioPharma

And many others.

Cryptococcal Meningitis Therapies Covered in the report include:

  • Amphotericin B

  • Lipo-AB

  • MAT2203

And many more.

Request for Sample @ Cryptococcal Meningitis Emerging Therapies and Key Companies

Table of Content

1. Key Insights

2. Executive Summary 

3. Cryptococcal Meningitis Competitive Intelligence Analysis

4. Cryptococcal Meningitis Market Overview at a Glance

5. Cryptococcal Meningitis Disease Background and Overview

6. Cryptococcal Meningitis Patient Journey

7. Cryptococcal Meningitis Epidemiology and Patient Population

8. Cryptococcal Meningitis Treatment Algorithm, Current Treatment, and Medical Practices

9. Cryptococcal Meningitis Unmet Needs

10. Key Endpoints of Cryptococcal Meningitis Treatment

11. Cryptococcal Meningitis Marketed Products

12. Cryptococcal Meningitis Emerging Therapies

13. Cryptococcal Meningitis Seven Major Market Analysis

14. Attribute Analysis

15. Cryptococcal Meningitis Market Outlook (7 major markets)

16. Cryptococcal Meningitis Access and Reimbursement Overview

17. KOL Views on the Cryptococcal Meningitis Market.

18. Cryptococcal Meningitis Market Drivers

19. Cryptococcal Meningitis Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at: https://www.delveinsight.com/sample-request/cryptococcal-meningitis-market

Latest Reports By DelveInsight

Primary Immune Deficiency (PID) Market

DelveInsight’s “Primary Immune Deficiency (PID) Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Primary Immune Deficiency (PID) market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Dementia with Diabetes Market

DelveInsight’s “Dementia with Diabetes Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Dementia with Diabetes market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/